News
(Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight ...
Eli Lilly launches Mounjaro KwikPen in India, offering adults with type 2 diabetes and obesity a once-weekly, ...
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...
Jason DeFord, also known as Jelly Roll, has inspired fans with his genre-bending music across country, rap and rock. His ...
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results